BR112014029874A8 - composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica - Google Patents
composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêuticaInfo
- Publication number
- BR112014029874A8 BR112014029874A8 BR112014029874A BR112014029874A BR112014029874A8 BR 112014029874 A8 BR112014029874 A8 BR 112014029874A8 BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A8 BR112014029874 A8 BR 112014029874A8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- compositions
- oil
- water emulsion
- emulsion type
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000007764 o/w emulsion Substances 0.000 title abstract 2
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 2
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica. composições farmacêuticas tópicas de tipo emulsão o/a que contêm um retinoide. a presente invenção trata de uma composição farmacêutica tópica que compreende como ativo farmacêutico, um retinoide em um meio fisiologicamente aceitável, de seu processo de preparação, e de seu uso em dermatologia.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261654694P | 2012-06-01 | 2012-06-01 | |
FR1255091 | 2012-06-01 | ||
US61/654,694 | 2012-06-01 | ||
FR1255091A FR2991175B1 (fr) | 2012-06-01 | 2012-06-01 | Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide |
PCT/EP2013/061199 WO2013178758A1 (fr) | 2012-06-01 | 2013-05-30 | Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014029874A2 BR112014029874A2 (pt) | 2017-06-27 |
BR112014029874A8 true BR112014029874A8 (pt) | 2021-08-24 |
BR112014029874B1 BR112014029874B1 (pt) | 2022-01-18 |
Family
ID=46826691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014029874-2A BR112014029874B1 (pt) | 2012-06-01 | 2013-05-30 | Composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica |
Country Status (12)
Country | Link |
---|---|
US (1) | US9855244B2 (pt) |
EP (1) | EP2874619B1 (pt) |
JP (1) | JP2015518033A (pt) |
KR (1) | KR102118226B1 (pt) |
CN (1) | CN104507470B (pt) |
AU (1) | AU2013269581B2 (pt) |
BR (1) | BR112014029874B1 (pt) |
CA (1) | CA2875417A1 (pt) |
FR (1) | FR2991175B1 (pt) |
MX (1) | MX357704B (pt) |
RU (1) | RU2655305C2 (pt) |
WO (1) | WO2013178758A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160235796A1 (en) * | 2015-02-13 | 2016-08-18 | Peter Kennedy | Topical vasodilator composition |
US10478466B1 (en) | 2015-02-13 | 2019-11-19 | Peter Kennedy | Topical vasodilator composition |
WO2017074982A1 (en) * | 2015-10-30 | 2017-05-04 | Patagonia Pharmaceuticals, Llc | Isotretinoin formulations and uses and methods thereof |
CN114929678B (zh) * | 2019-11-29 | 2023-08-15 | 石家庄迪斯凯威医药科技有限公司 | 一种取代的间三联苯类化合物及其药物组合物和用途 |
WO2024114789A1 (zh) * | 2022-12-02 | 2024-06-06 | 南京迈诺威医药科技有限公司 | 一种含有曲法罗汀的药物组合物及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK279919B6 (sk) * | 1993-07-01 | 1999-05-07 | Yamanouchi Europe B.V. | Farmaceutický a kozmetický prostriedok na miestne |
FR2709666B1 (fr) * | 1993-09-07 | 1995-10-13 | Oreal | Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire. |
FR2742677B1 (fr) * | 1995-12-21 | 1998-01-16 | Oreal | Nanoparticules enrobees d'une phase lamellaire a base de tensioactif silicone et compositions les contenant |
US5972355A (en) * | 1997-09-30 | 1999-10-26 | E-L Management Corp. | Stable compositions containing biologically active components |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
US20040213754A1 (en) * | 2000-10-02 | 2004-10-28 | Cole Curtis A. | Method for cleansing sensitive skin using an alkanolamine |
US6881414B2 (en) * | 2000-11-22 | 2005-04-19 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Mild cosmetic composition with stabilized retinoids |
ES2327508T3 (es) * | 2002-03-12 | 2009-10-30 | GALDERMA RESEARCH & DEVELOPMENT | Empleo de adapaleno para el tratamiento de trastornos dermatologicos. |
KR20070091613A (ko) * | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
FR2880020B1 (fr) * | 2004-12-23 | 2007-02-16 | Galderma Res & Dev | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
BRPI0517500B8 (pt) * | 2004-12-23 | 2021-05-25 | Galderma Res & Dev | composto, uso de uma composição, composição farmacêutica, composição cosmética, usos não-terapêuticos de uma composição cosmética e processo cosmético para melhorar a aparência da pele |
KR101365282B1 (ko) * | 2005-09-23 | 2014-02-19 | 디에스엠 아이피 어셋츠 비.브이. | 수산화지방산을 포함하는 화장품 조성물 |
FR2910320B1 (fr) * | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
FR2910321B1 (fr) * | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
FR2915682B1 (fr) * | 2007-05-04 | 2009-07-03 | Galderma Res & Dev | Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations |
RU2363461C2 (ru) * | 2007-10-03 | 2009-08-10 | Закрытое акционерное общество "Биологические исследования и системы" | Фармацевтический препарат для наружного и местного применения на основе сигетина |
CA2747939C (en) * | 2008-12-22 | 2016-11-08 | Thierry Oddos | A composition comprising a retinoid and method of treating skin conditions |
WO2010072958A2 (fr) * | 2008-12-23 | 2010-07-01 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
-
2012
- 2012-06-01 FR FR1255091A patent/FR2991175B1/fr not_active Expired - Fee Related
-
2013
- 2013-05-30 CA CA 2875417 patent/CA2875417A1/fr not_active Abandoned
- 2013-05-30 MX MX2014014579A patent/MX357704B/es active IP Right Grant
- 2013-05-30 WO PCT/EP2013/061199 patent/WO2013178758A1/fr active Application Filing
- 2013-05-30 US US14/404,877 patent/US9855244B2/en active Active
- 2013-05-30 RU RU2014152992A patent/RU2655305C2/ru active
- 2013-05-30 CN CN201380040802.9A patent/CN104507470B/zh active Active
- 2013-05-30 AU AU2013269581A patent/AU2013269581B2/en active Active
- 2013-05-30 KR KR1020147036857A patent/KR102118226B1/ko active IP Right Grant
- 2013-05-30 EP EP13726205.1A patent/EP2874619B1/fr active Active
- 2013-05-30 BR BR112014029874-2A patent/BR112014029874B1/pt active IP Right Grant
- 2013-05-30 JP JP2015514507A patent/JP2015518033A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2013178758A1 (fr) | 2013-12-05 |
KR102118226B1 (ko) | 2020-06-02 |
MX2014014579A (es) | 2015-03-03 |
CN104507470B (zh) | 2018-06-26 |
KR20150016984A (ko) | 2015-02-13 |
JP2015518033A (ja) | 2015-06-25 |
FR2991175A1 (fr) | 2013-12-06 |
RU2014152992A (ru) | 2016-07-27 |
AU2013269581A1 (en) | 2014-12-18 |
CN104507470A (zh) | 2015-04-08 |
EP2874619B1 (fr) | 2023-01-04 |
AU2013269581B2 (en) | 2018-03-01 |
MX357704B (es) | 2018-07-20 |
EP2874619A1 (fr) | 2015-05-27 |
BR112014029874B1 (pt) | 2022-01-18 |
RU2655305C2 (ru) | 2018-05-24 |
US9855244B2 (en) | 2018-01-02 |
BR112014029874A2 (pt) | 2017-06-27 |
US20150148400A1 (en) | 2015-05-28 |
CA2875417A1 (fr) | 2013-12-05 |
FR2991175B1 (fr) | 2014-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016000882A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15). | |
CR20140365A (es) | Compuestos de carbamato y preparación y uso de los mismos | |
GT201400164A (es) | Compuestos de imidazopirrolidinona | |
DOP2015000058A (es) | Derivados tricíclicos de quinolinas y de quinoxalinas | |
BR112015009189A2 (pt) | conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo | |
PH12015500850A1 (en) | Stable preservative-free mydriatic and anti-inflammatory solutions for injection | |
BR112015026023A2 (pt) | derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1 | |
BR112015018838A2 (pt) | estabilidade melhorada de novas composições líquidas | |
BRPI1106572B8 (pt) | Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso | |
BR112016011170A8 (pt) | derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica | |
BR112015006790A2 (pt) | composição de cetoprofeno tópico | |
BRPI0808979B8 (pt) | preparação, seu uso, e usos de butanol | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
AR125920A2 (es) | Composiciones que comprenden vortioxetina y donepezil | |
BR112014029885A8 (pt) | Composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água | |
BR112015009989A2 (pt) | estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase | |
BR112014029874A8 (pt) | composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica | |
BR112015026388A2 (pt) | métodos e composições para cicatrização de feridas | |
CY1121238T1 (el) | Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων | |
UY33417A (es) | Formulación que contiene acido azelaico con adición de pigmento | |
DOP2015000298A (es) | Compuestos nuevos para el tratamiento del cáncer | |
BR112015006692A2 (pt) | formulação de nanodispersão, método para administrar uma formulação de nanodispersão líquida de taxina livre de etanol em um indivíduo, e, kit. | |
MX2014014517A (es) | Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado. | |
AR100028A1 (es) | Composiciones nutricionales que contienen ácido estearidónico | |
BR112015030135A2 (pt) | ésteres de ácidos oligo-hidróxi carboxílicos e seu uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |